SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001140361-23-044775
Filing Date
2023-09-21
Accepted
2023-09-21 17:10:41
Documents
1
Group Members
DAVID C. OTTO. ANDREAS HALVORSENROSE S. SHABETVIKING GLOBAL OPPORTUNITIES DRAWDOWN (AGGREGATOR) LPVIKING GLOBAL OPPORTUNITIES DRAWDOWN GP LLCVIKING GLOBAL OPPORTUNITIES DRAWDOWN PORTFOLIO GP LLCVIKING GLOBAL OPPORTUNITIES GP LLCVIKING GLOBAL OPPORTUNITIES

Document Format Files

Seq Description Document Type Size
1 SC 13G ef20010907_sc13g.htm SC 13G 376962
  Complete submission text file 0001140361-23-044775.txt   378996
Mailing Address 600 WASHINGTON BLVD. FLOOR 11 STAMFORD CT 06901
Business Address 600 WASHINGTON BLVD. FLOOR 11 STAMFORD CT 06901 212-672-7050
VIKING GLOBAL INVESTORS LP (Filed by) CIK: 0001103804 (see all company filings)

IRS No.: 134055118 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 5505 MOREHOUSE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE, SUITE 300 SAN DIEGO CA 92121 (619) 937-2754
RayzeBio, Inc. (Subject) CIK: 0001825367 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94159 | Film No.: 231269736
SIC: 2834 Pharmaceutical Preparations